Suggestions
Jonathan Ozeran
Vice President at Tempus Labs, Experienced in AI and Venture Capital
Jonathan Ozeran is a prominent figure in the field of healthcare technology, currently serving as the Vice President of Generative AI and Head of Tempus One at Tempus, Inc. He has been an integral part of Tempus since its early days and has held various leadership roles, including Director of Product from 2016 to 2022 and Senior Director of Operations from 2022 to 2023.
Professional Background
At Tempus, Jonathan focuses on leveraging artificial intelligence to enhance precision medicine. He leads initiatives such as Tempus One, an AI-enabled clinical assistant designed to improve clinicians' access to molecular and clinical data, thereby facilitating data-driven treatment decisions for patients. His work involves scaling the use of advanced technologies across oncology provider networks, utilizing a vast dataset exceeding 100 petabytes.13
Before his current role, Jonathan was instrumental in developing clinical data structuring programs and clinical trial matching software at Tempus, which supports the TIME Trial Program, connecting oncologists and patients to cutting-edge clinical trials.32
Education and Early Career
Jonathan holds a Bachelor’s degree in Political Science from the University of Michigan and a Master’s degree in Computer and Information Systems from Northwestern University. His career spans over a decade, during which he has built and delivered software products across various sectors, including healthcare, life sciences, and telemedicine.12
Investment and Advisory Roles
In addition to his work at Tempus, Jonathan is an angel investor and advisor to several startups and venture funds, focusing on digital health, AI, and other innovative sectors. He actively participates in investment diligence and portfolio support for growth-phase companies.12
Jonathan Ozeran's expertise in product development, operations, and investment positions him as a key player in advancing technology within the healthcare industry, particularly in the realm of precision medicine.